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doi:10.1016/j.jtcvs.2007.10.091566 The Journal of Thoracic and CardObjective: The European System for Cardiac Operative Risk Evaluation has been
used to define a particularly high-risk group of patients for aortic valve replacement
in whom alternative procedures, such as stent-mounted percutaneous valve proce-
dures, may be appropriate. Our objective was to assess the validity of this risk assess-
ment at a large-volume, tertiary cardiac surgical center.
Methods: From January 1, 2000, to December 30, 2006, a total of 1177 patients un-
derwent isolated aortic valve replacement at the Mayo Clinic. Patient and operative
demographics were recorded in a prospective database. Early mortality (#30 days)
was obtained. Additive and logistic European System for Cardiac Operative Risk
Evaluations were calculated for each patient.
Results: Themean patient age was 68.0 years (614.7 years) at the time of surgery, and
36.8% were female. Variables used in the calculation of the European System for Car-
diac Operative Risk Evaluation included chronic lung disease (15% of our cohort),
extracardiac arteriopathy (13.8%), neurologic dysfunction (0.2%), previous cardiac
surgery (23.2%), renal failure (6.5%), active endocarditis (3.1%), recent myocardial
infarction (1.1%), unstable angina (0.1%), and severe pulmonary hypertension
(6.5%). The ejection fraction was severely reduced (#30%) in 4.9% of patients and
moderately reduced (#50%) in 12.7% of patients. One percent of patients were in
a critical state, and operation was performed urgently in 3.4% of patients. Although
mean mortality estimates were 6.9% 6 3.4% (additive European System for Cardiac
Operative Risk Evaluation) and 10.9% 6 12.7% (logistic European System for Car-
diac Operative Risk Evaluation), actual overall operative mortality in our patients was
2.5%. Additive and logistic European System for Cardiac Operative Risk Evaluations
overestimated operative mortality in low, intermediate, and high-risk subgroups by up
to 17.8%.
Conclusions: The European System for Cardiac Operative Risk Evaluation should not
be used to determine the operability of patients for isolated aortic valve replacement.
Elevated European System for Cardiac Operative Risk Evaluations alone do not
appropriately define a population for use of a percutaneous aortic valve.
R
isk scoring systems are tools to enable the comparison of patients’ risks. Risk
scores may be used for operative scheduling (urgency of operation), patient
care requirements and dismissal planning, and auditing of mortality and qual-
ity of care.1 However, scoring systems should not be used as substitutes for clinical
decision making.1 An ideal scoring system should be easy to use, have a clearly
defined outcome, and be used for auditing purposes.2iovascular Surgery c September 2008
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PAbbreviations and Acronyms
AVR 5 aortic valve replacement
CABG 5 coronary artery bypass grafting
EuroSCORE 5 European System for Cardiac
Operative Risk Evaluation
The introduction of novel technologies, such as percutane-
ous aortic valves, poses a significant ethical challenge be-
cause, at early stages of development, the results obtained
may be anticipated to be suboptimal. Their use is appropri-
ately restricted to extremely high-risk groups for whom con-
ventional procedures may be prohibited or unavailable.
Although highly sophisticated surgical risk-scoring systems
have been developed for purposes of quality assurance,
they are currently being used to define such groups.
The European System for Cardiac Operative Risk Evalu-
ation (EuroSCORE) is a risk scoring system designed to pre-
dict operative mortality in cardiac surgical patients. It was
designed because of the increasing numbers of high-risk pa-
tients undergoing cardiac surgery and a desire to provide risk-
adjusted mortality rates instead of only crude mortality rates.3
The additive EuroSCORE was the first model available for
use.3 However, because of concerns regarding the underesti-
mation of mortality in high-risk subsets, the logistic model
was made available.4,5 The additive model is still considered
adequate in most cases and has the advantage of being easily
calculated at the bedside.
Despite the limitations of scoring systems, investigators
studying new technologies such as percutaneous aortic
valves have implied that EuroSCORE may be a tool to iden-
tify patients at excessive operative risk for a traditional aortic
valve replacement (AVR).6-8 To test this theory, we reviewed
AVRs performed at the Mayo Clinic and compared our out-
comes with the predictive additive and logistic EuroSCORE
scoring systems.
Materials and Methods
Institutional review board approval was obtained for this study.
From January 1, 2000, to December 30, 2006, a total of 1177 pa-
tients underwent isolated AVR at the Mayo Clinic. Patients with
concomitant procedures including coronary artery bypass grafting
(CABG) and ascending aortic procedures were excluded. Patient
and operative demographics were recorded in a prospective database
according to the Society of Thoracic Surgeons Adult Database def-
initions. Early mortality (#30 days) was obtained for all patients us-
ing hospital records and the Accurint database (www.accurint.com).
The EuroSCORE research calculator available online was used
for both additive and logistic EuroSCORE calculations. The Euro-
SCORE considers 17 risk factors, including patient, cardiac, and op-
erative features, to estimate operative mortality.9 In the risk models,
patient characteristics associated with increased perioperative mor-
tality include older age, female gender, chronic pulmonary disease,
extracardiac arteriopathy, neurologic disease, previous cardiac sur-The Journal of Thogery, elevated serum creatinine, active endocarditis, and a critical
preoperative state (Table 1).5 Cardiac-related factors include unsta-
ble angina requiring intravenous nitrates, left ventricular dysfunc-
tion, recent myocardial infarction, and pulmonary hypertension.
Operation-related factors include emergency surgery, other proce-
dures than isolated CABG, surgery on the thoracic aorta, and post-
infarction septal rupture.1,9 Both additive and logistic EuroSCOREs
were calculated for each patient.
The definitions in the Society of Thoracic Surgery Adult Cardiac
Surgery Database were matched exactly to those in the EuroSCORE
models whenever possible. Extracardiac arteriopathy was defined as
peripheral vascular disease, which included claudication, either with
exertion or rest, amputation for arterial insufficiency, aortoiliac oc-
clusive disease reconstruction, peripheral vascular bypass surgery,
angioplasty, or stent, documented abdominal aneurysm or repair/
stent, or documented positive noninvasive testing. Patients who
had a history of cerebrovascular disease were also included (unre-
sponsive coma .24 hours, cerebrovascular event, transient isc-
hemic attack, noninvasive carotid test with .75% occlusion, or
previous carotid surgery). Patients who had a recent cerebral vascu-
lar accident (,72 hours) were considered to have neurologic
disease. Previous cardiac surgery requiring opening of the pericar-
dium included only those who had previous surgery using cardio-
pulmonary bypass. Those patients in cardiogenic shock (systolic
blood pressure ,80 mm Hg and/or cardiac index ,1.8 despite
maximal treatment or intravenous inotropes and/or intra-aortic bal-
loon pump necessary to maintain blood pressure .80 and/or car-
diac index .1.8) were defined as having a critical preoperative
state. All patients in this study had an isolated AVR and thus had
an ‘‘operation other than isolated coronary artery bypass grafting
(CABG).’’
Patient characteristics were entered into the EuroSCORE addi-
tive and logistic models. The calculated scores were used as predic-
tors for operative mortality (,30 days) in a logistic regression
model. Receiver operating curves were created for the overall group
comparing both additive and logistic models. Patients were then di-
vided into low-risk (additive# 5, logistic# 0.05), intermediate-risk
(additive 6–10, logistic 0.051–0.10), and high-risk (additive $11,
logistic $0.101) groups, and the observed and expected number
of events for these risk groups were compared using chi-square or
Fisher exact tests as appropriate. Analysis was performed using
SAS 9.1 (SAS Inc, Cary, NC).
Results
The mean age at the time of AVR was 68 years (614.7
years), and 37% were female. Fifteen percent of patients
had chronic lung disease, 13.8% of patients had extracardiac
arteriopathy, 0.2% of patients had neurologic dysfunction,
23.2% of patients had previous cardiac surgery, 6.5% of pa-
tients had renal failure, 3.1% of patients had active endocar-
ditis, 1.1% of patients had a recent myocardial infarction,
0.1% of patients had unstable angina, 1.1% of patients had re-
cent myocardial infarction, and 6.5% of patients had severe
pulmonary hypertension. The ejection fraction was severely
reduced (#30%) in 4.9% of patients and moderately reduced
(#50%) in 12.7% of patients. One percent of patients were in
a critical state, and urgent surgery was performed in 3.4% ofracic and Cardiovascular Surgery c Volume 136, Number 3 567
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Patient-related factors Definition Additive score Logistic score
Age Per 5 y or part thereof . 60 y 1 0.0666354
Sex Female 1 0.3304052
Chronic pulmonary disease Long-term use of bronchodilators or steroids
for lung disease
1 0.4931341
Extracardiac arteriopathy Any one or more of the following: claudication, carotid
occlusion, or . 50% stenosis, previous or planned
intervention on the abdominal aorta, limb arteries
or carotids
2 0.6558917
Neurologic dysfunction
disease
Severely affecting ambulation or day-to-day functioning 2 0.841626
Previous cardiac surgery Any previous cardiac surgery requiring opening the
pericardium
2 1.002625
Serum creatinine .200 mmol/L preoperatively 2 0.6521653
Active endocarditis Patient still receiving antibiotic treatment for
endocarditis at the time of surgery
3 1.101265
Critical preoperative state Any one or more of the following: ventricular tachycardia,
fibrillation, or aborted sudden death, preoperative cardiac
massage, preoperative ventilation before arrival to the OR,
preoperative inotropic support, intra-aortic balloon
counterpulsation, or preoperative acute renal failure
(anuria or oliguria , 10 mL/h)
3 0.9058132
Cardiac-related
Unstable angina Rest angina requiring IV nitrates until arrival in the
anesthetic room
2 0.5677075
LV dysfunction Moderate (EF 30%–50%) 1 0.4191643
poor (EF , 30%) 3 1.094443
Recent myocardial infarction ,90 d before surgery 2 0.5460218
Pulmonary hypertension Systolic PA pressure . 60 mm Hg 2 0.7676924
Operation-related factors
Emergency OR before the beginning of the next working day 2 0.7127953
Other than isolated CABG Major cardiac procedures other than or
in addition to CABG
2 0.5420364
Surgery on thoracic aorta Ascending, arch, or descending aorta 3 1.159787
Postinfarction septal rupture Ventricular septal rupture postinfarction 4 1.462009
Intercept value For logistic model only NA 24.789594
OR, Operating room; IV, intravenous; LV, left ventricular; EF, ejection fraction; PA, pulmonary artery; CABG, coronary artery bypass grafting.patients. All patients had a procedure other than CABG (ie,
AVR), and no patients had an aortic aneurysm repair or post-
infarction ventricular septal defect. This is shown in Table 2
along with the patient characteristics from the original Euro-
SCORE model.
The area under the curve for the receiver operating curve
was 0.75 for the additive score and 0.75 for the logistic score,
with P values of less than .001 (Figure 1). This indicated that
both additive and logistic EuroSCORE models were reason-
ably good predictors of operative mortality for the whole
group. When the receiver operating curve area under the
curve was compared between the additive and logistic Euro-
SCOREs, there was no significant difference (P5 .329). The
observed operative mortality (,30 days) was 2.5% (30/1177
patients). The actual and estimated mortalities are shown in
Figure 2.568 The Journal of Thoracic and Cardiovascular Surgery c SepAdditive EuroSCORE
In the low-risk group (additive EuroSCORE # 5), the esti-
mated mean mortality was 3.5% 6 1.2%, compared with
the observed mortality of 3 of 435 patients (0.7%) (P 5
.004) (Figure 3, A). In the intermediate-risk group (additive
EuroSCORE 6–10), the estimated mean mortality was
7.7% 6 1.4%, compared with the observed mortality of 14
of 567 patients (2.5%) (P , .001). The high-risk group (ad-
ditive EuroSCORE$ 11) had an estimated mean mortality of
12.6% 6 2.0%, compared with the observed mortality of 13
of 175 patients (7.4%) (P 5 .109).
Logistic EuroSCORE
In the low-risk group (logistic EuroSCORE # 0.05), the
estimated mean mortality was 2.8% 6 1.1%, compared
with the observed mortality of 3 of 491 patients (0.6%)tember 2008
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P(P 5 .007) (Figure 3, B). In the intermediate-risk group (lo-
gistic EuroSCORE 0.051–0.10), the estimated mean mortal-
ity was 7.1%6 1.5%, compared with the observed mortality
of 4 of 283 patients (1.4%) (P, .001). In the high-risk group
(logistic EuroSCORE$ 0.101, the estimated mean mortality
was 23.6% 6 14.8%, compared with the observed mortality
of 23 of 399 patients (5.7%) (P , .001).
Discussion
With the advent of less-invasive technologies, physicians look
to models of operative risk to identify patients who are ex-
pected to have high periprocedural mortality. In recent reports
of percutaneous and transapical AVR, investigators have used
additive and logistic EuroSCOREs as evidence of the high op-
erative risk with a traditional AVR in these patients.6-8,10-13
Our study demonstrates that both the additive and logistic
EuroSCORE models substantially overestimate mortality in
all risk subgroups at a large-volume referral center.
In 1999, the results of the EuroSCORE was published
using information on risk factors and mortality on 19,030 pa-
tients who underwent cardiac surgery using cardiopulmonary
bypass fromSeptember toDecember of 1995 in 128European
centers.3 A total of 68 preoperative and 29 operative factors
were collected, and a logistic regression model was used to
estimate operative mortality. Although this study has been
validated in the CABG population,14,15 there were only
3200 patients who underwent AVR (17%) in the original
cohort of 19,030 patients. As a consequence, the models are
TABLE 2. Patient characteristics
Parameter
EuroSCORE
N 5 19,030
Mayo isolated
AVR N 5 1177
Mean age (6SD) y 62.5 6 10.7 68.0 6 14.7
Female (%) 27.8 36.8
Chronic pulmonary disease (%) 3.9 15.0
Extracardiac arteriopathy (%) 11.3 13.8
Neurologic dysfunction (%) 1.4 0.2
Previous cardiac surgery (%) 7.3 23.2
Serum creatinine
. 200 mmol/L (%)
1.8 6.5
Active endocarditis (%) 1.1 3.1
Critical preoperative state (%) 4.1 1.0
LVEF 30%–50% (%) 25.6 12.7
LVEF ,30% (%) 5.8 4.9
Recent myocardial
infarction (%)
9.7 1.1
Pulmonary hypertension (%) 2.0 6.5
Emergency (%) 4.9 3.4
Other than isolated CABG (%) 36.4 100
Surgery on thoracic aorta (%) 2.4 0
Postinfarction septal rupture (%) 0.2 0
EuroSCORE, European System for Cardiac Operative Risk Evaluation; AVR,
aortic valve replacement; SD, standard deviation; LVEF, left ventricular ejec-
tion fraction; CABG, coronary artery bypass grafting.The Journal of Thordesigned so that CABG is considered the baseline risk and
any valve procedure is designated as a ‘‘procedure other
than CABG.’’ Thus, mitral valve repair, mitral valve replace-
ment, AVR, or any of the previous procedures with concom-
itant bypass grafting will result in the same EuroSCORE risk
profile. Therefore, the relatively lower risk procedures, such
as an isolated AVR, may result in an ‘‘elevated’’ risk predic-
tion in both EuroSCORE models.
The Society of Thoracic Surgeons reported an operative
mortality of approximately 3.5% in 2006 for an isolated
Figure 1. Receiver operator curve of the additive and logistic
EuroSCORE models compared with the actual mortality after AVR.
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Figure 2. Actual and predicted mortality for the logistic Euro-
SCORE model. The mortality rate is on the Y axis, and patients
are divided into groups on the basis of the predicted additive Euro-
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spite that 23% of patients had at least one previous cardiac
procedure requiring cardiopulmonary bypass and 18% of pa-
tients had a reduced left ventricular ejection fraction. We be-
lieve that there are few true contraindications to traditional
AVR in patients with severe aortic valve stenosis. Most pa-
tients who do not undergo AVR are unlikely to be candidates
for any interventional procedure because of comorbidities
such as dementia or cancer.
The definition of ‘‘inoperability’’ is difficult, as evidenced
by the ‘‘conversion’’ of such patients to open traditional pro-
cedures after percutaneous misadventures. In the study by
Grube and colleagues,7 6 ‘‘inoperable’’ patients required ur-
gent conversion to an open procedure to retrieve the devices
and implanted aortic prostheses with only 1 operative death.
In the series from Vancouver reported by Webb and col-
leagues,11 1 patient had successful balloon dilatation but
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Figure 3. A, Additive EuroSCORE predicted mortality versus ob-
served mortality in risk subgroups. Patients were divided into
risk groups on the basis of additive EuroSCORE (low# 5, interme-
diate 6–10, high $ 11). B, Logistic EuroSCORE predicted mortality
versus observed mortality in risk subgroups. Patients were di-
vided into risk groups on the basis of logistic EuroSCORE (low
# 0.05, intermediate 0.051–0.10, and high $ 0.101). *Statistically
significant difference. Int, Intermediate.570 The Journal of Thoracic and Cardiovascular Surgery c Sepunsuccessful deployment of an aortic valve. This patient
had successful elective AVR 4 months later. Thus, although
these patients were considered high risk by EuroSCORE cri-
teria, they underwent successful traditional AVR, which
questions their ‘‘inoperable’’ designation.
Our study is limited because the definitions recorded in
our databases do not exactly match those in the EuroSCORE
risk calculators. The definitions provided by EuroSCORE are
broad, especially neurologic disease dysfunction, which is
defined as ‘‘severely affecting ambulation or day-to-day
functioning.’’ This could be interpreted multiple ways. In
our study, we limited this to patients who had a stroke within
the last 72 hours. We included only patients who had prior
cardiopulmonary bypass as ‘‘prior cardiac surgery,’’ and
only patients in cardiogenic shock were considered as ‘‘crit-
ical preoperative state.’’ As such, we think our definitions
were conservative.
Conclusions
Less-invasive aortic valve procedures will undoubtedly find
a place within current cardiac surgical practice. However, cli-
nicians must be cautious in estimating operative risk from
models that were not intended for this specific use. In our
practice, both additive and logistic EuroSCORE risk models
overestimate operative mortality for isolated AVR, and this
overestimation is greatest in high-risk patients.
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